Study to gather information about the actual use of an adhesive patch placed on the skin to deliver Oxytrol through the skin into the bloodstream.
With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.
- Female - 18 years of age or older - Not pregnant or suspected to be pregnant - Never trained or employed as a healthcare professional - Neither the subject nor anyone in their household worked for a pharmaceutical company, a pharmacy, a managed care or health insurance company, a healthcare practice, or as a healthcare professional - Had not participated in any market research study, product label study or clinical trial in the past 12 months
- Symptoms of blood in the urine not related to menses - Back pain and fever in conjunction with frequency or urgency and any of the following: dysuria, hematuria, or cloudy urine - Narrow-angle glaucoma - Pregnant (as determined by a urine pregnancy test among women of child bearing potential) - Breastfeeding - Known allergy to oxybutynin
Stevenson Family Pharmacy
St. Joseph, United States, 64504
E-mail: [email protected]
Phone: Not Available
An Oxytrol Transdermal System Actual Use Study (Consumer Trial of Oxytrol, Control)
Single Group Assignment